These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 17879949
1. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype. Garcia FU, Haber MM, Chen X. Prostate; 2007 Nov 01; 67(15):1686-92. PubMed ID: 17879949 [Abstract] [Full Text] [Related]
2. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Sanderson SO, Sebo TJ, Murphy LM, Neumann R, Slezak J, Cheville JC. Am J Clin Pathol; 2004 Feb 01; 121(2):220-5. PubMed ID: 14983935 [Abstract] [Full Text] [Related]
3. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA. Am J Clin Pathol; 2004 Oct 01; 122(4):517-23. PubMed ID: 15487448 [Abstract] [Full Text] [Related]
4. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH, Signoretti S, Loda M. Mod Pathol; 2002 Dec 01; 15(12):1302-8. PubMed ID: 12481011 [Abstract] [Full Text] [Related]
5. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma. Iczkowski KA, Pantazis CG, McGregor DH, Wu Y, Tawfik OW. Cancer; 2002 Dec 15; 95(12):2487-93. PubMed ID: 12467061 [Abstract] [Full Text] [Related]
6. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia. Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML. Clin Cancer Res; 1999 Dec 15; 5(12):4105-10. PubMed ID: 10632347 [Abstract] [Full Text] [Related]
7. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Oliai BR, Kahane H, Epstein JI. Am J Surg Pathol; 2002 Sep 15; 26(9):1151-60. PubMed ID: 12218571 [Abstract] [Full Text] [Related]
8. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases. Bostwick DG, Qian J, Maihle NJ. Prostate; 2004 Feb 01; 58(2):164-8. PubMed ID: 14716741 [Abstract] [Full Text] [Related]
9. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia. Jack GS, Brash AR, Olson SJ, Manning S, Coffey CS, Smith JA, Shappell SB. Hum Pathol; 2000 Sep 01; 31(9):1146-54. PubMed ID: 11014584 [Abstract] [Full Text] [Related]
10. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI. Am J Surg Pathol; 2007 Aug 01; 31(8):1246-55. PubMed ID: 17667550 [Abstract] [Full Text] [Related]
11. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis. Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK. Hum Pathol; 2010 Aug 01; 41(8):1145-9. PubMed ID: 20413145 [Abstract] [Full Text] [Related]
12. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy. Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L. Hum Pathol; 2007 Feb 01; 38(2):332-41. PubMed ID: 17134736 [Abstract] [Full Text] [Related]
13. Expression of ezrin in prostatic intraepithelial neoplasia. Pang ST, Fang X, Valdman A, Norstedt G, Pousette A, Egevad L, Ekman P. Urology; 2004 Mar 01; 63(3):609-12. PubMed ID: 15028477 [Abstract] [Full Text] [Related]
14. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases. Zhao J, Epstein JI. Am J Surg Pathol; 2009 Apr 01; 33(4):583-90. PubMed ID: 19033862 [Abstract] [Full Text] [Related]
15. Pigment in prostatic epithelium and adenocarcinoma: a potential source of diagnostic confusion with seminal vesicular epithelium. Amin MB, Bostwick DG. Mod Pathol; 1996 Jul 01; 9(7):791-5. PubMed ID: 8832564 [Abstract] [Full Text] [Related]
16. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J. Mod Pathol; 1996 Oct 01; 9(10):1015-9. PubMed ID: 8902840 [Abstract] [Full Text] [Related]
17. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Am J Surg Pathol; 2002 Sep 01; 26(9):1161-8. PubMed ID: 12218572 [Abstract] [Full Text] [Related]
18. Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Maygarden SJ, Strom S, Ware JL. Arch Pathol Lab Med; 1992 Mar 01; 116(3):269-73. PubMed ID: 1371380 [Abstract] [Full Text] [Related]